Dr. Miles Medical Co. v. John D. Park & Sons Co.

Background

The dispute is between a maker of proprietary medicines that uses secret formulas and a wholesale drug house that refused to join the maker’s required contracts. The manufacturer used two interlocking agreements — a “consignment” form made with over four hundred jobbers and wholesale dealers and a “retail agency” form signed by about twenty-five thousand retailers — to try to fix minimum prices and control who could buy and resell its products. The defendant is accused of obtaining medicines for resale at “cut prices.”

Reasoning

The core question was whether those contracts could lawfully fix resale prices across interstate trade. The Court rejected the idea that secrecy of the manufacturing process or analogy to patents gave the maker special power to control later sales. The opinion explains that the manufacturer had no statutory grant like a patent, and that once its goods enter trade ordinary freedom of resale must be preserved. The Court held the interlocking price and buyer restrictions unreasonable as a restraint on trade and invalid both at common law and under the act of July 2, 1890.

Real world impact

The decision prevents a manufacturer from using a widespread system of contracts to fix minimum retail prices nationwide and thereby to eliminate competition among wholesalers and retailers. The judgment affirmed the lower court’s conclusion and denied relief based on trade-mark or label claims when the price-restraint claim failed.

Dissents or concurrances

Justice Holmes dissented, arguing courts should not block such business arrangements absent clear public harm, and he viewed the manufacturer’s plan as one way to manage distribution and prices.